Clinical Trial Update: A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System

View source ↗

Summary

This post-marketing study evaluated on-label performance of GE's Vscan handheld ultrasound imaging system.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pulmonary Hypertension
• Right Heart Failure
• Valvular Heart Disease

Snippet

Sponsor: GE Healthcare | Conditions: Left Ventricular Dysfunction, Right Ventricular Dysfunction | Status: COMPLETED | Results posted: 2016-03-07